While both target metabolism through different mechanisms, combining them requires careful medical oversight and individual assessment
[10] [16] Whilst similar specific guidance does not yet exist for GLP-1 receptor agonists, clinical vigilance regarding nutritional status is prudent, especially in patients experiencing significant weight loss or gastrointestinal symptoms
The most common side effects of GLP-1 drugs are gastrointestinal, such as nausea, vomiting, and diarrhea
There have also been reports of gallbladder disease, including cholelithiasis (gallstones) and cholecystitis, possibly related to rapid weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 273
What does the refund policy actually say